Molecular Docking and<i> In Silico</i> ADMET Study Reveals Acylguanidine 7a as a Potential Inhibitor of <i>β</i>-Secretase

<div>Docking of rosiglitazone with 1SGZ protein.</div>

Advances in Bioinformatics

Figure 6: Molecular Docking and<i> In Silico</i> ADMET Study Reveals Acylguanidine 7a as a Potential Inhibitor of <i>β</i>-Secretase 